Annotation Detail for AGA

Basic Information
Top
| Desease ID | Desease Name |
|---|
| Lysosomal storage diseases |
| H00145 | Aspartylglucosaminuria |
| Genetic disorders |
| Desease Name |
|---|
| Aspartylglucosaminuria |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C031903 |
1-UFT protocol |
AGA protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of AGA mRNA | affects expression | 21346803
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of AGA mRNA | affects expression | 17562736
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of AGA mRNA | increases expression | 20106945
|
| D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of AGA mRNA | increases expression | 16807920
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of AGA mRNA | increases expression | 18175754
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.36 | 10982225 |
| MESH:D054880 |
Aspartylglucosaminuria |
marker/mechanism |
|
| |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
2.94 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.94 | 3084413 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.75 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.27 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.27 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.44 | 18551238 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.67 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.67 | 11834606 12958197 15968718 12705907 12392966 11529661 16227642 19739265 16109766 10663392 10774834 18071297 19085960 12153990 14986274 16781746 16177239 19416960 16081117 12540782 19420014 11287661 18713872 17522070 2444490 10915739 16393943 11421492 19923254 11461765 15619225 17906064 19164858 14725611 19370779 14550746 12594235 17562736 16485898 11743745 11739529 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.67 | 15131321 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.62 | 19426721 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.18 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12639820 12168785 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.19 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.95 | 16870215 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.34 | 15629191 12587719 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.34 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.18 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.18 | 12371664 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 16610002 12969438 12587719 19460945 11587558 19784758 16611625 19014921 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.54 | 16871587 17185352 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.24 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.72 | 2876784 2876786 6135515 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.98 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 7678174 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 19348381 18481113 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.14 | 18514411 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.74 | 16049721 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.65 | 16870215 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.74 | 18551238 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.39 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.33 | 10982225 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |